Early Detection and Advanced Imaging for Gynecologic Cancers
Ovarian, uterine, cervical, and other gynecological cancers are among the most common cancers affecting women.
1
Unfortunately, many women may be unaware of the often vague symptoms or may hesitate to seek medical advice due to embarrassment or the stigma associated with these diagnoses. This has a big impact since early diagnosis is crucial, as it significantly impacts survival rates and quality of life.
By sharing knowledge on the latest technologies and best practices, we can enhance early detection and provide more effective treatments to minimize the impact of these cancers. To keep sharing this knowledge, we organized the second webinar of the “Breast and Gynecology Days”, focused on gynecologic oncology.
Unfortunately, many women may be unaware of the often vague symptoms or may hesitate to seek medical advice due to embarrassment or the stigma associated with these diagnoses. This has a big impact since early diagnosis is crucial, as it significantly impacts survival rates and quality of life.
By sharing knowledge on the latest technologies and best practices, we can enhance early detection and provide more effective treatments to minimize the impact of these cancers. To keep sharing this knowledge, we organized the second webinar of the “Breast and Gynecology Days”, focused on gynecologic oncology.
Day 2 | Gynecologic Oncology
Ultrasound / MRI
October 31, 7 pm (CET) / 2 pm (EDT)
Mark your calendar and join Prof. Testa , Prof. Moro , and Dr. Olmane as they discuss gynecologic oncology through the lenses of ultrasound and MRI. The experts will share their insights on cutting-edge technologies for screening and imaging-guided therapy, offering practical guidance to improve patient outcomes.
Register now for this second appointment with the "Breast and Gynecology Days," the webinar series made possible by the Canon Medical Academy.
Program
Certificate*
All delegates will receive a certificate of attendance.
October 31, 7 pm (CET) / 2 pm (EDT)
Mark your calendar and join Prof. Testa , Prof. Moro , and Dr. Olmane as they discuss gynecologic oncology through the lenses of ultrasound and MRI. The experts will share their insights on cutting-edge technologies for screening and imaging-guided therapy, offering practical guidance to improve patient outcomes.
Register now for this second appointment with the "Breast and Gynecology Days," the webinar series made possible by the Canon Medical Academy.
Program
- Introduction | Prof. Antonia Carla Testa
- Preoperative Ultrasound Assessment of Patients with Gynecological Cancer | Prof. Francesca Moro
- Advanced MR imaging in Female pelvic oncology: diagnostic insights and Clinical Application | Dr. Evija Olmane
- Live Q&A, moderated by Prof. Antonia Carla Testa
- Recognize the role of advanced ultrasound in detecting gynecological malignancies and aiding preoperative planning
- Diagnose and stage gynecological cancer based on key clinical cases and imaging
- Participating in the live Q&A to find answers to your own questions
Certificate*
All delegates will receive a certificate of attendance.
Speakers and Presentations
Moderator: Prof. Antonia Carla Testa Associate Professor and Scientific Director
Agostino Gemelli University Hospital Foundation
Rome, Italy
Discover More About the Moderator
Agostino Gemelli University Hospital Foundation
Rome, Italy
Speaker: Prof. Francesca Moro, MD, PhD Gynecologist and obstetrician
Agostino Gemelli University Hospital, Catholic University of the Sacred Heart
Rome, Italy
Presentation: Preoperative ultrasound assessment of patients with gynecological cancer
Ultrasound is the primary imaging tool for assessing ovarian masses, effectively differentiating benign from malignant adnexal masses and guiding patient management. It has emerged as an alternative to contrast-enhanced CT and WB-DWI/MRI for staging ovarian cancer, with experienced examiners accurately predicting carcinomatosis and surgical outcomes.
Ultrasound is also pivotal in evaluating endometrial and cervical cancers, offering detailed cancer invasion mapping that informs tailored strategies such as radiochemotherapy versus surgery, including fertility-sparing options.
Advances in ultrasound now include artificial intelligence and radiomics. In the future, high-frequency ultrasound is likely to play a role in the management of these women.
Discover More About the Speaker
Agostino Gemelli University Hospital, Catholic University of the Sacred Heart
Rome, Italy
Presentation: Preoperative ultrasound assessment of patients with gynecological cancer
Ultrasound is the primary imaging tool for assessing ovarian masses, effectively differentiating benign from malignant adnexal masses and guiding patient management. It has emerged as an alternative to contrast-enhanced CT and WB-DWI/MRI for staging ovarian cancer, with experienced examiners accurately predicting carcinomatosis and surgical outcomes.
Ultrasound is also pivotal in evaluating endometrial and cervical cancers, offering detailed cancer invasion mapping that informs tailored strategies such as radiochemotherapy versus surgery, including fertility-sparing options.
Advances in ultrasound now include artificial intelligence and radiomics. In the future, high-frequency ultrasound is likely to play a role in the management of these women.
Speaker: Dr. Evija Olmane, MD Radiologist, chief radiologist
Ars. Diagnostic Clinic
Riga, Latvia
Presentation: Advanced MR imaging in Female pelvic oncology: diagnostic insights and Clinical Application
Cervical cancer is the 4th most common cancer in women globally, with most cases and deaths occurring in low-to-middle-income countries. Persistent HPV infection is the primary risk factor, responsible for 99% of cases, and another risk factor is HIV. Symptoms may include vaginal bleeding, pelvic pain, and dyspareunia, although it can be asymptomatic. Diagnosis is made through cervical cytology and biopsy.
Endometrial cancer is the most common gynecological cancer. The FIGO staging system is used for surgical staging, and MRI plays a key role in treatment planning and follow-up by providing vital information on tumor characteristics, invasion, extrauterine extent, and lymph node status.
Ovarian carcinoma is the 2nd most common gynecological malignancy and the 5th leading cause of cancer death in women. High-grade serous cystadenocarcinoma is responsible for most ovarian cancer deaths. When ultrasound results are inconclusive, the positive predictive value of cancer can range from 7% to 50%.
Discover More About the Speaker
Ars. Diagnostic Clinic
Riga, Latvia
Presentation: Advanced MR imaging in Female pelvic oncology: diagnostic insights and Clinical Application
Cervical cancer is the 4th most common cancer in women globally, with most cases and deaths occurring in low-to-middle-income countries. Persistent HPV infection is the primary risk factor, responsible for 99% of cases, and another risk factor is HIV. Symptoms may include vaginal bleeding, pelvic pain, and dyspareunia, although it can be asymptomatic. Diagnosis is made through cervical cytology and biopsy.
Endometrial cancer is the most common gynecological cancer. The FIGO staging system is used for surgical staging, and MRI plays a key role in treatment planning and follow-up by providing vital information on tumor characteristics, invasion, extrauterine extent, and lymph node status.
Ovarian carcinoma is the 2nd most common gynecological malignancy and the 5th leading cause of cancer death in women. High-grade serous cystadenocarcinoma is responsible for most ovarian cancer deaths. When ultrasound results are inconclusive, the positive predictive value of cancer can range from 7% to 50%.
Discover More About the Moderator and Speakers
Prof. Antonia Carla Testa Prof. Antonia Testa is a leading European expert in gynecologic oncology, with over fifty research projects on gynecological cancer and chemotherapy. She founded a renowned gynecology ultrasound school in Rome, which has trained thousands of specialists.
Prof. Testa is an Associate Professor at the Catholic University of the Sacred Heart and Scientific Director of the Center for Ultrasound in Gynecological Oncology at Fondazione Policlinico Agostino Gemelli IRCCS, Rome.
She has served on the boards of ISUOG and SIGO, and is a Steering Committee member of the International Ovarian Tumor Analysis (IOTA) group.
Prof. Francesca Moro, MD, PhD Prof. Francesca Moro is an expert in gynecological cancer working at Policlinico Universitario Agostino Gemelli.
She started her career in Medicine and Surgery at the Faculty of Medicine and Surgery Università Cattolica del Sacro Cuore, Rome. She specialized further at the same university in gynecology and obstetrics, and spent 2 years as a fellow at University College Hospital, London (UCLH).
She has a PhD in “Clinical, Cellular, and Molecular Research”.
She is also a Visiting Professor at the National Institute of Health – named after academician S. Avdalbekian – and a Visiting Professor at the Medicine Faculty in Las Palmas de Gran Canaria University.
Dr. Evija Olmane, MD Dr. Olmane is a highly experienced physician-radiologist with over 20 years of expertise in diagnostic radiology. She has been involved in international research on prostate and bladder cancer, contributing to multiple publications. She has worked at leading institutions, including Paula Stradins Clinical University Hospital and Medical Centre ARS, where she heads the diagnostic radiology department.
Specializing in ultrasonography (USG) for abdominal organs, CT of the abdomen, and MRI of the abdomen and pelvis (prostate and gynecological MR), Dr. Olmane continually advances her skills through international courses. She also trains residents at P. Stradiņa KU hospital and is an active member of several radiology associations, including the European Association of Radiologists and ESGAR.
Don't Miss the Other Breast & Gynecology Days
References
1
ESGO, ENGAGe | Gynecological Cancers in Europe | 2018
Gynaelogical-cancer-final.pdf (esgo.org)
Disclaimers
Due to medical device regulatory reasons, not all products/services displayed on this Canon Medical Systems webpage are available in all countries or markets. Future availability of the products/service cannot also be guaranteed. Don't hesitate to contact your local Canon Medical Systems representative for further details.
